17-61482983-TC-TCC
Position:
Variant summary
Our verdict is Pathogenic. Variant got 14 ACMG points: 14P and 0B. PVS1_StrongPM2PP5_Very_Strong
The NM_001321120.2(TBX4):c.1115dupC(p.Pro373fs) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: not found (cov: 32)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
TBX4
NM_001321120.2 frameshift
NM_001321120.2 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 7.57
Genes affected
TBX4 (HGNC:11603): (T-box transcription factor 4) This gene is a member of a phylogenetically conserved family of genes that share a common DNA-binding domain, the T-box. T-box genes encode transcription factors involved in the regulation of developmental processes. This gene is the human homolog of mouse Tbx4, which is closely linked to Tbx2 on mouse chromosome 11. Similarly this gene, like TBX2, maps to human chromosome 17. Expression studies in mouse and chicken show that Tbx4 is expressed in developing hindlimb, but not in forelimb buds, suggesting a role for this gene in regulating limb development and specification of limb identity. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 14 ACMG points.
PVS1
Loss of function variant, product does not undergo nonsense mediated mRNA decay. Variant is located in the 3'-most exon, not predicted to undergo nonsense mediated mRNA decay. Fraction of 0.32 CDS is truncated, and there are 0 pathogenic variants in the truncated region.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 17-61482983-T-TC is Pathogenic according to our data. Variant chr17-61482983-T-TC is described in ClinVar as [Likely_pathogenic]. Clinvar id is 812880.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TBX4 | NM_001321120.2 | c.1115dupC | p.Pro373fs | frameshift_variant | 9/9 | ENST00000644296.1 | NP_001308049.1 | |
TBX4 | NM_018488.3 | c.1112dupC | p.Pro372fs | frameshift_variant | 8/8 | NP_060958.2 | ||
TBX4 | XM_011525490.3 | c.1304dupC | p.Pro436fs | frameshift_variant | 9/9 | XP_011523792.1 | ||
TBX4 | XM_011525491.3 | c.1301dupC | p.Pro435fs | frameshift_variant | 9/9 | XP_011523793.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TBX4 | ENST00000644296.1 | c.1115dupC | p.Pro373fs | frameshift_variant | 9/9 | NM_001321120.2 | ENSP00000495986.1 | |||
TBX4 | ENST00000240335.1 | c.1112dupC | p.Pro372fs | frameshift_variant | 8/8 | 1 | ENSP00000240335.1 | |||
TBX4 | ENST00000589449.5 | n.874dupC | non_coding_transcript_exon_variant | 7/8 | 1 | |||||
TBX4 | ENST00000642491.1 | c.1115dupC | p.Pro373fs | frameshift_variant | 8/8 | ENSP00000495714.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 genomes
Cov.:
32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1461790Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 727194
GnomAD4 exome
Data not reliable, filtered out with message: AC0
AF:
AC:
0
AN:
1461790
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
727194
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 32
GnomAD4 genome
Cov.:
32
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4Other:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Pulmonary arterial hypertension Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | NIHR Bioresource Rare Diseases, University of Cambridge | - | - - |
Primary pulmonary hypoplasia;C1840061:Coxopodopatellar syndrome Pathogenic:1
Likely pathogenic, no assertion criteria provided | research | Stankiewicz Research Laboratory, Baylor College of Medicine | - | Variants involving TBX4 are associated with a wide variety of disorders, including pulmonary arterial hypertension, ischiocoxopodopatellar syndrome (ICPPS), lethal lung developmental disorders (LLDDs) in neonates, heart defects, and prenatally lethal posterior amelia with pelvic and pulmonary hypoplasia syndrome. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 02, 2023 | ClinVar contains an entry for this variant (Variation ID: 812880). For these reasons, this variant has been classified as Pathogenic. This variant disrupts a region of the TBX4 protein in which other variant(s) (p.Gln531Arg) have been determined to be pathogenic (PMID: 15106123). This suggests that this is a clinically significant region of the protein, and that variants that disrupt it are likely to be disease-causing. This premature translational stop signal has been observed in individual(s) with TBX4-related conditions (PMID: 15106123, 29650961, 30578397, 32860008). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Pro372Serfs*14) in the TBX4 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 174 amino acid(s) of the TBX4 protein. - |
Coxopodopatellar syndrome Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Centogene AG - the Rare Disease Company | - | - - |
Coxopodopatellar syndrome;C4552070:Pulmonary hypertension, primary, 1 Other:1
not provided, no classification provided | literature only | Wendy Chung Laboratory, Columbia University Medical Center | - | - - |
Pulmonary hypertension, primary, 1 Other:1
not provided, no classification provided | literature only | Wendy Chung Laboratory, Columbia University Medical Center | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at